- Home
- IMRN vs SYNX Comparison
IMRN vs SYNX Comparison
Compare IMRN & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SYNX
- Stock Information
- Founded
- IMRN 1994
- SYNX 2005
- Country
- IMRN Australia
- SYNX Israel
- Employees
- IMRN N/A
- SYNX N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SYNX
- Sector
- IMRN Health Care
- SYNX
- Exchange
- IMRN Nasdaq
- SYNX Nasdaq
- Market Cap
- IMRN 10.3M
- SYNX 11.9M
- IPO Year
- IMRN N/A
- SYNX 2024
- Fundamental
- Price
- IMRN $1.71
- SYNX $1.85
- Analyst Decision
- IMRN Strong Buy
- SYNX
- Analyst Count
- IMRN 1
- SYNX 0
- Target Price
- IMRN $5.00
- SYNX N/A
- AVG Volume (30 Days)
- IMRN 11.8K
- SYNX 30.5K
- Earning Date
- IMRN 05-27-2025
- SYNX 05-14-2025
- Dividend Yield
- IMRN N/A
- SYNX N/A
- EPS Growth
- IMRN N/A
- SYNX N/A
- EPS
- IMRN N/A
- SYNX N/A
- Revenue
- IMRN $4,048,286.00
- SYNX $9,094,000.00
- Revenue This Year
- IMRN N/A
- SYNX N/A
- Revenue Next Year
- IMRN N/A
- SYNX N/A
- P/E Ratio
- IMRN N/A
- SYNX N/A
- Revenue Growth
- IMRN 82.90
- SYNX 19.14
- 52 Week Low
- IMRN $1.60
- SYNX $1.70
- 52 Week High
- IMRN $2.87
- SYNX $6.49
- Technical
- Relative Strength Index (RSI)
- IMRN 41.94
- SYNX 39.25
- Support Level
- IMRN $1.87
- SYNX $1.82
- Resistance Level
- IMRN $2.13
- SYNX $2.06
- Average True Range (ATR)
- IMRN 0.15
- SYNX 0.13
- MACD
- IMRN -0.01
- SYNX 0.07
- Stochastic Oscillator
- IMRN 32.71
- SYNX 41.67
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.